4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-23-000242
EVP CLO & General Counsel sold 20,825 shares at $51.46 ($1,071,717)
- EVP CLO & General Counsel acquired 20,825 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
O'NEIL PATRICK R. · EVP CLO & General Counsel
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-12-26 | Exercise or conversion : show line 1 in the form 10b5-1 | +20,825 | $47.34 | $985,856 | 61,180 | D |
| 2023-12-26 | Sale : show line 2 in the form 10b5-1 | −20,825 | $51.46 | $1,071,717 | 40,355 | D |
| Open-market sales · 20,825 sh · avg $51.46 · $1,071,717 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2023-12-26 | Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −20,825 | $47.34 | 2024-01-02 | 20,825 | 0 | D |
Loading xslF345X05/edgardoc.xml…